This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
100
Personalized video-based stroke education platform
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Patient satisfaction with stroke education (90 days)
5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Time frame: 90 days
Stroke etiology recognition (90 days)
The proportion of patients who correctly identify their stroke etiology
Time frame: 90 days
Stroke risk factor recognition (90 days)
The proportion of patients who correctly identify at least one of their vascular risk factors
Time frame: 90 days
Stroke prevention medication recognition (7 days)
The proportion of patients who correctly identify their antithrombotic medications
Time frame: 7 days
Stroke prevention medication recognition (90 days)
The proportion of patients who correctly identify their antithrombotic medications
Time frame: 90 days
Patient satisfaction with stroke education (7 days)
5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Time frame: 7 days
Stroke etiology recognition (7 days)
The proportion of patients who correctly identify their stroke etiology
Time frame: 7 days
Stroke risk factor recognition (7 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The proportion of patients who correctly identify at least one of their vascular risk factors
Time frame: 7 days
Stroke patient education retention (SPER) survey (7 days)
total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
Time frame: 7 days
Stroke patient education retention (SPER) survey (90 days)
total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
Time frame: 90 days
EuroQOL - visual analog scale (7 days)
patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)
Time frame: 7 days
EuroQOL - visual analog scale (90 days)
patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)
Time frame: 90 days
modified Rankin Scale
Ordinal functional disability scale (score 0 - 6)
Time frame: 90 days
Medication adherence (7 days)
total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)
Time frame: 7 days
Medication adherence (90 days)
total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)
Time frame: 90 days